Clintec International Expands Capabilities with the Accreditation of the Latest Generation of Medidata Rave EDCt

London, February 27, 2018: Clintec International, an award winning, global Clinical Research Organisation (CRO), enhances its data management capabilities to include Medidata’s (NASDAQ: MDSO) latest generation of RAVE EDC (electronic data capture) to ensure superior operational efficiency and advanced functionality.

We, at Clintec are pleased to announce further expansion of our partnership with Medidata.  Clintec received accreditation in RAVE EDC, upgrading its suite of offerings on the Medidata Clinical Cloud^® platform. As a Medidata Partner, we have implemented the industry-leading electronic data capture, management and reporting solution  (Rave EDC), the coding solution (Rave Coder), and Medidata’s clinical trial management (Edge CTMS) platforms.

Clintec’s newest advancement, Medidata’s latest Rave EDC, makes our processes more agile and scalable allowing us to offer customised and flexible solutions to our clients. Speaking about this upgraded accreditation, Dr. Buttar, Clintec International chief executive officer said, “Medidata RAVE EDC will enable us to provide our clients with the state-of-the-art capabilities that they require. It further enhances our clinical research efficiencies—accelerating study timelines, reducing development costs, while providing the highest quality. We’re excited to use this cutting-edge technology solution on Medidata’s industry-leading, unified cloud platform to manage clinical trials across all therapeutic areas and therefore elevate our client services.”

“We’re thrilled that Clintec is further expanding its use of our unified platform to include the latest generation of Rave EDC,” said Glen de Vries, Medidata president and co-founder. “This marks an important milestone in providing their clients with the full breadth of Rave solutions to improve the quality and the efficiency of global studies.”

Corporate Comm India(CCI Newswire)